NLS Collaboration

Biopharmaceutical research company MedImmune and the U.S. Department of Commerce’s National Institute of Standards and Technology are partners in a five-year research and development project to produce  new medications or therapies using biological instead of  chemical components. MedImmune is  U.K.-based AstraZeneca PLC’s biologics research and development unit . It will provide funding for seven scientists for the first year. Each of the scientists will work on a […]

To give some potential drugs a second chance, AstraZeneca PLC, GlaxoSmithKline and  five other companies have created a library of 68 compounds that did not make it to market, in the hope is that one of the other partners will be able to complete development and get the product on the market. AstraZeneca reached an agreement with the Medical […]

Danish biotech company Acesion Pharma, which is actively developing therapeutic treatments for atrial fibrillation (AF), has raised 15.2 million DKK (2.5 million USD) in a new equity investment round. The round includes Boston-based Broadview Ventures as a new investor and current investor Novo Seeds. The company is working on a treatment to prevent the recurrence […]

Biopharmaceutical company Xencor, Inc. announced that it has entered a collaboration agreement with Novo Nordisk to discover new drug candidates by combining Xencor XmAb technologies. The research and development deal has the potential to bring in $175 million for Xencor. Both companies will use the bispecific technology to build molecular formats that can target and […]

Genmab A/S announced it has reached a milestone in its DuoBody technology platform collaboration with Janssen Biotech, Inc., triggering a $3 million payment.  The milestone payment is for pre-clinical progress with a DuoBody product candidate targeting cancer. “This milestone marks further progress in our DuoBody collaboration with Janssen.  There are now 10 bispecific antibody programs […]

Medicon Village, a Swedish cluster for life sciences, visited Wales’ new center for life sciences this month. The visit builds on a relationship which began 18 months ago when Life Sciences Hub Wales was chosen as Medicon Village’s first “twin.” The two organizations identified a number of areas where they can share knowledge and collaborate. […]